R.n.a Delivery — compliance record
The full vetting file: federal registrations, authority history, insurance, inspections, record changes, and recent coverage — the checks a broker or shipper runs, in one place.
Vetting summary
Inspections
Zero inspections on file — no safety data to evaluate (a documented gap in vetting standards)
Federal identity
Registration snapshot
Legal name
Andrew M Amezquita
DBA
R.n.a Delivery
Entity type
Carrier
Physical address
1429 S San Dimas Avenue, Bloomington, CA 92316
Phone
(626) 423-3746
Power units
1
Drivers
1
First on record
—
Last MCS-150 filing
—
Hazmat flag
No
Operating authority
Dockets & filings
No L&I dockets on file for this DOT number.
Crash record — last 24 months
0
Reportable crashes
0
Tow-aways
0
With injuries
0
With fatalities
Safety record
Inspection history
No roadside inspections in the current federal dataset.
Activity log
Record changes
TenFourHQ re-syncs the federal record daily and logs every field that changes — address moves, fleet-size jumps, authority flips. Sudden changes are a classic fraud tell.
No changes recorded since TenFourHQ began tracking this company.
In the news
Recent coverage
Engineering the biophysical properties of lipid nanostructures for drug delivery - Nature
Nature · 1/24/2026
Red Blood Cell Membrane Vesicles for siRNA Delivery: A Biocompatible C | IJN - Dove Medical Press
Dove Medical Press · 3/15/2025
Endosomal escape: A bottleneck for LNP-mediated therapeutics - PNAS
PNAS · 3/4/2024
mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer - ScienceDirect.com
ScienceDirect.com · 1/3/2024
Cationic Polystyrene Latex Nanocarriers for Immunostimulatory Long Double-Stranded RNA Delivery to Ovarian Cancer Cells - Wiley Online Library
Wiley Online Library · 9/25/2024
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy - Frontiers
Frontiers · 2/16/2023
Intramuscular delivery of formulated RNA encoding six linked nanobodies is highly protective for exposures to three Botulinum neurotoxin serotypes | Scientific Reports - Nature
Nature · 7/8/2022
Quantum dots as biocompatible small RNA nanocarriers modulating macrophage polarization to treat Asherman’s syndrome - Nature
Nature · 3/25/2025
Via Google News — headlines may include similarly-named companies; verify before acting.
Vetting toolkit
Verify it yourself
FMCSA SAFER snapshot ↗
The official company snapshot, straight from FMCSA.
FMCSA SMS safety profile ↗
Safety Measurement System — BASIC scores and crash history.
L&I authority record ↗
Licensing & Insurance: authority, insurance, and BOC-3 on file.
Search court records ↗
Quick sweep for litigation and judgments.